2015-2019 U.S. POC/Point-of-Care Hematology and Flow Cytometry Markets: Physician Offices, Emergency Rooms, Operating Suites, ICUs/CCUs, Cancer Clinics, Ambulatory Care Centers, Surgery Centers, Nursing Homes, Birth Centers - Supplier Shares, Country Forecasts, Emerging Technologies, Competitive Strategies
This new 238-page report from VPGMarketResearch contains 38 tables, and provides a comprehensive analysis of thePOC hematology and flow cytometry market, including trends, dynamics, size, growth, regulatory requirements, technological trends, competitive landscape, and emerging opportunities for instrument and consumable suppliers. This report will help diagnostic product suppliers develop effective business, R&D and marketing strategies for the global POC hematology and flow cytometry market. RationaleThe growing economic pressures on hospitals, coupled with advances in diagnostic technologies, intensifying competition among suppliers and physicians, and changing consumer demands are shifting diagnostic testing from hospitals and commercial laboratories closer to the patient. Market Segmentation Analysis- Review of nine POC market segments, including their dynamics, trends, structure, size, growth and major suppliers. - Five-year test volume and reagent sales forecasts for hematology and flow cytometry procedures by market segment:- Physician Offices/Group Practices- Emergency Rooms - Operating/Recovery Suites- ICUs/CCUs- Cancer Clinics- Ambulatory Care Centers- Surgery Centers- Nursing Homes- Birth CentersSales and Market Share Analysis- Sales and market shares of major hematology and flow cytometry reagent and instrument suppliers. Instrument Placements and Installed Base- The report provides estimates of annual placements and total installed base for major hematology and flow cytometry analyzers. Current and Emerging Products- Analysis of hematology and flow cytometry procedures performed in POC testing locations. - Review of leading hematology and flow cytometry analyzers, both currently marketed and those in development, including their operating characteristics, features and selling prices. Technology Review- Emerging technologies and their applications for POC testing. - Comprehensive listings of companies developing or marketing hematology and flow cytometry testing technologies and products, by assay. Competitive Assessments- Assessments of major suppliers and emerging market entrants, including their sales, product portfolios, marketing tactics, joint ventures, and new products in R&D. Strategic Recommendations- Specific opportunities for new hematology and flow cytometry instruments and reagent systems with potentially significant market appeal during the next five years. - Design criteria for POC testing products. - Alternative business expansion strategies.Potential market entry barriers and risks. MethodologyThis report is based on a combination of primary and secondary sources of information, including review of the latest technical and business publications, manufacturer product literature, industry analyst reports, and VPGMarketResearch's proprietary data files. Contains 238 pages and 38 tables
INTRODUCTION
EXECUTIVE SUMMARY
RATIONALE FOR TESTING DECENTRALIZATION
1. OVERVIEW
2. REGULATORY TRENDS
3. ECONOMIC TRENDS
4. DEMOGRAPHIC TRENDS
5. TECHNOLOGICAL TRENDS
6. SOCIAL TRENDS
7. QUALITY OF CARE
8. DEFENSIVE MEDICINE
9. QUALITY CONTROL ISSUES
REVIEW OF CLINICAL CHEMISTRY TESTS
1. ALBUMIN
2. ALKALINE PHOSPHATASE
3. ALT/SGPT
4. AMMONIA
5. AMYLASE
6. AST/SGOT
7. BILIRUBIN
8. BLOOD GASES
9. BLOOD UREA NITROGEN (BUN)
10. CALCIUM
11. CHOLESTEROL
12. CHOLINESTERASE
13. CREATININE
14. ELECTROLYTES
a. Carbon Dioxide/Bicarbonate
b. Chloride
c. Potassium
d. Sodium
15. FERRITIN
16. FOLLATE/FOLIC ACID
17. FRUCTOSAMINE
18. GAMMA-GLUTAMYL TRANSPEPTIDASE (GGT)
19. GLUCOSE
20. HIGH DENSITY LIPOPROTEIN (HDL)
21. IRON
22. LACTATE DEHYDROGENASE (LDH)
23. MAGNESIUM
24. PHOSPHORUS
25. PROTEIN
26. TRIGLYCERIDES
27. TROPONIN
28. URIC ACID
29. URINALYSIS
30. VITAMIN B12
INSTRUMENTATION: Chemistry Analyzers Manufactured by:
Abaxis
Abbott
Alfa Wassermann
Awareness Technologies
Beckman Coulter/Danaher
bioMeriuex
Carolina Chemistries
Horiba
Inverness
Medica
Nova Biomedical
Ortho-Clinical Diagnostics
Polimedco
Randox
Roche
CURRENT AND EMERGING TECHNOLOGIES
1. MONOCLONAL ANTIBODIES
2. IMMUNOASSAYS
a. Technological Principle
b. Enzyme Immunoassays (EIA)
Overview
ELISA
Dot Immunobinding Assays
Capillary Immunoassays
Particle-Membrane Capture Immunoassay
Enzyme Amplification
c. Fluorescent Immunoassays
Fluorescent Polarization
Time-Resolved Pulse Fluorescence
d. Luminescence
Chemiluminescence
Bioluminescence
e. Latex Agglutination
f. Immunoprecipitation
3. DRY CHEMISTRY
4. BIOSENSORS
5. IT AND AUTOMATION
6. MOLECULAR DIAGNOSTICS
a. Technology Overview
b. Amplification Methods
Polymerase Chain Reaction
Ligase Chain Reaction
Branched DNA
Q-Beta Replicase
Strand Displacement Activation
Self-Sustained Sequence Replicase
U.S.A.
A. Market Overview
1. BUSINESS ENVIRONMENT
a. Health Care Expenditures
b. Cost Consciousness
c. Reimbursement
d. Industry Consolidation
e. Managed Care
PPO
HMO
f. Hospitals
g. Admissions
h. Length of Stay
i. Industry Diversification
j. Physician Demographics
k. Aging Population
More Chronic Illness
Disease Incidence
Susceptibility to latrogenesis
Multiple Illnesses Cases
l. Laboratory Regulations
2. MARKET STRUCTURE
a. Hospitals
b. Commercial/Private Laboratories
B. Physician Offices/Group Practices
1. MARKET SUMMARY
2. MARKET STRUCTURE
3. TEST VOLUME AND SALES FORECASTS
C. Ancillary Hospital Locations
1. INTRODUCTION
a. Emergency Departments
b. Operating Suites
c. Intensive Care Units
2. EMERGENCY DEPARTMENTS
a. Market Summary
b. Test volume and Sales Forecasts
3. OPERATING AND RECOVERY SUITES
a. Market Summary
b. Test Volume and Sales Forecasts
4. ICUS/CCUS A. MARKET SUMMARY
b. Test Volume and Sales Forecasts
D. Cancer Clinics
1. INTRODUCTION
2. MARKET SUMMARY
3. TEST VOLUME AND SALES FORECASTS
E. Ambulatory Care Centers
1. INTRODUCTION
2. MARKET SUMMARY
3. MARKET STRUCTURE
4. TEST VOLUME AND SALES FORECASTS
F. Surgery Centers
1. INTRODUCTION
2. MARKET SUMMARY
3. MARKET STRUCTURE
4. TEST VOLUME AND SALES FORECASTS
G. Nursing Homes
1. INTRODUCTION
2. MARKET SUMMARY
3. MARKET STRUCTURE
4. TEST VOLUME AND SALES FORECASTS
H. Birth Centers
1. INTRODUCTION
2. MARKET SUMMARY
3. MARKET STRUCTURE
4. TEST VOLUME AND SALES FORECASTS
1. MAJOR SUPPLIERS’ SALES AND MARKET SHARES
MAJOR PRODUCT DEVELOPMENT OPPORTUNITIES
DESIGN CRITERIA FOR DECENTRALIZED TESTING PRODUCTS
ALTERNATIVE MARKET PENETRATION STRATEGIES
A. Internal Development
B. Collaborative Arrangements
C. University Contracts
D. Distribution Strategies for Decentralized Testing Markets
1. MARKETING APPROACHES
2. PRODUCT COMPLEXITY
3. CUSTOMER PREFERENCE
4. ESTABLISHED SUPPLIERS
5. EMERGING SUPPLIERS
6. MAJOR TYPES OF DISTRIBUTORS
7. MARKET SEGMENTATION
POTENTIAL MARKET ENTRY BARRIERS AND RISKS
A. Market Maturity
B. Cost Containment
C. Competition
D. Technological Edge and Limitations
E. Patent Protection
F. Regulatory Constraints
G. Decentralized Testing Market Challenges
COMPANY PROFILE
Abbott Laboratories
AdnaGen/Alere
Agilent Technologies
Bayer Healthcare
Beckman Coulter/Danaher
Biomedical Diagnostics
BioMerieux
Bio-Rad
DiaSorin
Eiken
Fujirebio
Grifols
INSTRUMENTATION Laboratory
Kyowa Medex
Matritech/Alere
Ortho-Clinical Diagnostics
Quest Diagnostics
Roche
Siemens
Sysmex
Thermo Fisher
Tosoh
Wako
Wallac/PE
EXECUTIVE SUMMARY
RATIONALE FOR TESTING DECENTRALIZATION
1. OVERVIEW
2. REGULATORY TRENDS
3. ECONOMIC TRENDS
4. DEMOGRAPHIC TRENDS
5. TECHNOLOGICAL TRENDS
6. SOCIAL TRENDS
7. QUALITY OF CARE
8. DEFENSIVE MEDICINE
9. QUALITY CONTROL ISSUES
REVIEW OF CLINICAL CHEMISTRY TESTS
1. ALBUMIN
2. ALKALINE PHOSPHATASE
3. ALT/SGPT
4. AMMONIA
5. AMYLASE
6. AST/SGOT
7. BILIRUBIN
8. BLOOD GASES
9. BLOOD UREA NITROGEN (BUN)
10. CALCIUM
11. CHOLESTEROL
12. CHOLINESTERASE
13. CREATININE
14. ELECTROLYTES
a. Carbon Dioxide/Bicarbonate
b. Chloride
c. Potassium
d. Sodium
15. FERRITIN
16. FOLLATE/FOLIC ACID
17. FRUCTOSAMINE
18. GAMMA-GLUTAMYL TRANSPEPTIDASE (GGT)
19. GLUCOSE
20. HIGH DENSITY LIPOPROTEIN (HDL)
21. IRON
22. LACTATE DEHYDROGENASE (LDH)
23. MAGNESIUM
24. PHOSPHORUS
25. PROTEIN
26. TRIGLYCERIDES
27. TROPONIN
28. URIC ACID
29. URINALYSIS
30. VITAMIN B12
INSTRUMENTATION: Chemistry Analyzers Manufactured by:
Abaxis
Abbott
Alfa Wassermann
Awareness Technologies
Beckman Coulter/Danaher
bioMeriuex
Carolina Chemistries
Horiba
Inverness
Medica
Nova Biomedical
Ortho-Clinical Diagnostics
Polimedco
Randox
Roche
CURRENT AND EMERGING TECHNOLOGIES
1. MONOCLONAL ANTIBODIES
2. IMMUNOASSAYS
a. Technological Principle
b. Enzyme Immunoassays (EIA)
Overview
ELISA
Dot Immunobinding Assays
Capillary Immunoassays
Particle-Membrane Capture Immunoassay
Enzyme Amplification
c. Fluorescent Immunoassays
Fluorescent Polarization
Time-Resolved Pulse Fluorescence
d. Luminescence
Chemiluminescence
Bioluminescence
e. Latex Agglutination
f. Immunoprecipitation
3. DRY CHEMISTRY
4. BIOSENSORS
5. IT AND AUTOMATION
6. MOLECULAR DIAGNOSTICS
a. Technology Overview
b. Amplification Methods
Polymerase Chain Reaction
Ligase Chain Reaction
Branched DNA
Q-Beta Replicase
Strand Displacement Activation
Self-Sustained Sequence Replicase
U.S.A.
A. Market Overview
1. BUSINESS ENVIRONMENT
a. Health Care Expenditures
b. Cost Consciousness
c. Reimbursement
d. Industry Consolidation
e. Managed Care
PPO
HMO
f. Hospitals
g. Admissions
h. Length of Stay
i. Industry Diversification
j. Physician Demographics
k. Aging Population
More Chronic Illness
Disease Incidence
Susceptibility to latrogenesis
Multiple Illnesses Cases
l. Laboratory Regulations
2. MARKET STRUCTURE
a. Hospitals
b. Commercial/Private Laboratories
B. Physician Offices/Group Practices
1. MARKET SUMMARY
2. MARKET STRUCTURE
3. TEST VOLUME AND SALES FORECASTS
C. Ancillary Hospital Locations
1. INTRODUCTION
a. Emergency Departments
b. Operating Suites
c. Intensive Care Units
2. EMERGENCY DEPARTMENTS
a. Market Summary
b. Test volume and Sales Forecasts
3. OPERATING AND RECOVERY SUITES
a. Market Summary
b. Test Volume and Sales Forecasts
4. ICUS/CCUS A. MARKET SUMMARY
b. Test Volume and Sales Forecasts
D. Cancer Clinics
1. INTRODUCTION
2. MARKET SUMMARY
3. TEST VOLUME AND SALES FORECASTS
E. Ambulatory Care Centers
1. INTRODUCTION
2. MARKET SUMMARY
3. MARKET STRUCTURE
4. TEST VOLUME AND SALES FORECASTS
F. Surgery Centers
1. INTRODUCTION
2. MARKET SUMMARY
3. MARKET STRUCTURE
4. TEST VOLUME AND SALES FORECASTS
G. Nursing Homes
1. INTRODUCTION
2. MARKET SUMMARY
3. MARKET STRUCTURE
4. TEST VOLUME AND SALES FORECASTS
H. Birth Centers
1. INTRODUCTION
2. MARKET SUMMARY
3. MARKET STRUCTURE
4. TEST VOLUME AND SALES FORECASTS
1. MAJOR SUPPLIERS’ SALES AND MARKET SHARES
MAJOR PRODUCT DEVELOPMENT OPPORTUNITIES
DESIGN CRITERIA FOR DECENTRALIZED TESTING PRODUCTS
ALTERNATIVE MARKET PENETRATION STRATEGIES
A. Internal Development
B. Collaborative Arrangements
C. University Contracts
D. Distribution Strategies for Decentralized Testing Markets
1. MARKETING APPROACHES
2. PRODUCT COMPLEXITY
3. CUSTOMER PREFERENCE
4. ESTABLISHED SUPPLIERS
5. EMERGING SUPPLIERS
6. MAJOR TYPES OF DISTRIBUTORS
7. MARKET SEGMENTATION
POTENTIAL MARKET ENTRY BARRIERS AND RISKS
A. Market Maturity
B. Cost Containment
C. Competition
D. Technological Edge and Limitations
E. Patent Protection
F. Regulatory Constraints
G. Decentralized Testing Market Challenges
COMPANY PROFILE
Abbott Laboratories
AdnaGen/Alere
Agilent Technologies
Bayer Healthcare
Beckman Coulter/Danaher
Biomedical Diagnostics
BioMerieux
Bio-Rad
DiaSorin
Eiken
Fujirebio
Grifols
INSTRUMENTATION Laboratory
Kyowa Medex
Matritech/Alere
Ortho-Clinical Diagnostics
Quest Diagnostics
Roche
Siemens
Sysmex
Thermo Fisher
Tosoh
Wako
Wallac/PE
LIST OF TABLES
Major Companies Developing or Marketing Albumin Tests
Major Companies Developing or Marketing Alkaline Phosphatase Tests
Major Companies Developing or Marketing ALT/SGPT Tests
Major Companies Developing or Marketing Amylase Tests
Major Companies Developing or Marketing AST/SGOT Tests
Major Companies Developing or Marketing Bilirubin Tests
Major Companies Developing or Marketing Blood Gas Analyzers
Major Companies Developing or Marketing BUN Tests
Major Companies Developing or Marketing Calcium Tests
Major Companies Developing or Marketing Cholesterol Tests
Major Companies Developing or Marketing Creatinine Tests
Major Companies Developing or Marketing Electrolyte Tests
Major Companies Developing or Marketing Ferritin Tests
Major Companies Developing or Marketing GGT Tests
Major Companies Developing or Marketing Glucose Tests
Major Companies Developing or Marketing HDL Tests
Major Companies Developing or Marketing Iron Tests
Major Companies Developing or Marketing LDH Tests
Major Companies Developing or Marketing Magnesium Tests
Major Companies Developing or Marketing Phosphorus Tests
Major Companies Developing or Marketing Protein Tests
Major Companies Developing or Marketing Triglycerides Tests
Major Companies Developing or Marketing Uric Acid Tests
Major Companies Developing or Marketing Vitamin B-12/Folate Tests
U.S.A., Physician Office/Group Practice Laboratories Forecast by Practice Size
U.S.A., Physician Offices/Group Practices Forecast by Type
U.S.A., Office-Based Physicians Forecast by Practice Type
U.S.A., Physician Offices/Group Practices Routine and Special Chemistry Test Volume Forecast
U.S.A., Physician Offices/Group Practices Routine and Special Chemistry Test Volume Forecast by Practice Type
U.S.A., Physician Offices/Group Practices Routine and Special Chemistry Reagent Market Forecast By Test
U.S.A., Ancillary Hospital Locations Estimated Number
U.S.A., Ancillary Hospital Locations Annual Utilization
U.S.A., Hospital Emergency Departments Routine And Special Chemistry Test Volume Forecast
U.S.A., Hospital Emergency Departments Profiles, Panels and Individual Tests
U.S.A., Hospital Emergency Departments Routine and Special Chemistry Reagent Market Forecast by Test
U.S.A., Hospital Operating and Recovery Suites Routine and Special Chemistry Test Volume Forecast
U.S.A., Hospital Operating and Recovery Suites Routine and Special Chemistry Reagent Market Forecast by Test
U.S.A., Hospital ICUs/CCUs Routine And Special Chemistry Test Volume Forecast
U.S.A., Hospital ICUs/CCUs Routine And Special Reagent Market Forecast by Test
U.S.A., Cancer Clinics Routine And Special Chemistry Test Volume Forecast
U.S.A., Cancer Clinics Routine and Special Chemistry Reagent Market Forecast by Test
U.S.A., Ambulatory Care Centers Estimated Number of Facilities and Patient Visits
U.S.A., Ambulatory Care Centers Most Frequent Diagnoses
U.S.A., Ambulatory Care Centers Routine And Special Chemistry Test Volume Forecast
U.S.A., Ambulatory Care Centers Routine And Special Chemistry Reagent Market Forecast by Test
U.S.A., Surgery Centers Most Frequently Performed Procedures
U.S.A., Surgery Centers Routine And Special Chemistry Test Volume Forecast
U.S.A., Surgery Centers Routine And Special Chemistry Reagent Market Forecast by Test
U.S.A., Nursing Homes Estimated Number of Facilities, Beds and Occupancy Rate
U.S.A., Nursing Homes Routine And Special Chemistry Test Volume Forecast
U.S.A., Nursing Homes Routine And Special Chemistry Reagent Market Forecast by Test
U.S.A., Birth Centers Facilities, Patient Visits, and Births
U.S.A., Birth Centers Routine And Special Chemistry Test Volume Forecast
U.S.A., Birth Centers Profiles, Panels and Individual Tests
U.S.A., Birth Centers Routine And Special Chemistry Reagent Market Forecast by Test
U.S.A., Major Suppliers of Clinical Chemistry Diagnostic Products Estimated Market Shares
U.S.A., Major Suppliers of Clinical Chemistry Reagents, Estimated Market Shares
U.S.A., Major Suppliers of Clinical Chemistry Analyzers, Estimated Market Shares
U.S.A., Major Suppliers of Immunodiagnostic Products, Estimated Market Shares
U.S.A., Major Suppliers of Immunoassay Reagents, Estimated Market Shares
U.S.A., Major Suppliers of Immunoassay Analyzers, Estimated Market Shares
Major Companies Developing or Marketing Albumin Tests
Major Companies Developing or Marketing Alkaline Phosphatase Tests
Major Companies Developing or Marketing ALT/SGPT Tests
Major Companies Developing or Marketing Amylase Tests
Major Companies Developing or Marketing AST/SGOT Tests
Major Companies Developing or Marketing Bilirubin Tests
Major Companies Developing or Marketing Blood Gas Analyzers
Major Companies Developing or Marketing BUN Tests
Major Companies Developing or Marketing Calcium Tests
Major Companies Developing or Marketing Cholesterol Tests
Major Companies Developing or Marketing Creatinine Tests
Major Companies Developing or Marketing Electrolyte Tests
Major Companies Developing or Marketing Ferritin Tests
Major Companies Developing or Marketing GGT Tests
Major Companies Developing or Marketing Glucose Tests
Major Companies Developing or Marketing HDL Tests
Major Companies Developing or Marketing Iron Tests
Major Companies Developing or Marketing LDH Tests
Major Companies Developing or Marketing Magnesium Tests
Major Companies Developing or Marketing Phosphorus Tests
Major Companies Developing or Marketing Protein Tests
Major Companies Developing or Marketing Triglycerides Tests
Major Companies Developing or Marketing Uric Acid Tests
Major Companies Developing or Marketing Vitamin B-12/Folate Tests
U.S.A., Physician Office/Group Practice Laboratories Forecast by Practice Size
U.S.A., Physician Offices/Group Practices Forecast by Type
U.S.A., Office-Based Physicians Forecast by Practice Type
U.S.A., Physician Offices/Group Practices Routine and Special Chemistry Test Volume Forecast
U.S.A., Physician Offices/Group Practices Routine and Special Chemistry Test Volume Forecast by Practice Type
U.S.A., Physician Offices/Group Practices Routine and Special Chemistry Reagent Market Forecast By Test
U.S.A., Ancillary Hospital Locations Estimated Number
U.S.A., Ancillary Hospital Locations Annual Utilization
U.S.A., Hospital Emergency Departments Routine And Special Chemistry Test Volume Forecast
U.S.A., Hospital Emergency Departments Profiles, Panels and Individual Tests
U.S.A., Hospital Emergency Departments Routine and Special Chemistry Reagent Market Forecast by Test
U.S.A., Hospital Operating and Recovery Suites Routine and Special Chemistry Test Volume Forecast
U.S.A., Hospital Operating and Recovery Suites Routine and Special Chemistry Reagent Market Forecast by Test
U.S.A., Hospital ICUs/CCUs Routine And Special Chemistry Test Volume Forecast
U.S.A., Hospital ICUs/CCUs Routine And Special Reagent Market Forecast by Test
U.S.A., Cancer Clinics Routine And Special Chemistry Test Volume Forecast
U.S.A., Cancer Clinics Routine and Special Chemistry Reagent Market Forecast by Test
U.S.A., Ambulatory Care Centers Estimated Number of Facilities and Patient Visits
U.S.A., Ambulatory Care Centers Most Frequent Diagnoses
U.S.A., Ambulatory Care Centers Routine And Special Chemistry Test Volume Forecast
U.S.A., Ambulatory Care Centers Routine And Special Chemistry Reagent Market Forecast by Test
U.S.A., Surgery Centers Most Frequently Performed Procedures
U.S.A., Surgery Centers Routine And Special Chemistry Test Volume Forecast
U.S.A., Surgery Centers Routine And Special Chemistry Reagent Market Forecast by Test
U.S.A., Nursing Homes Estimated Number of Facilities, Beds and Occupancy Rate
U.S.A., Nursing Homes Routine And Special Chemistry Test Volume Forecast
U.S.A., Nursing Homes Routine And Special Chemistry Reagent Market Forecast by Test
U.S.A., Birth Centers Facilities, Patient Visits, and Births
U.S.A., Birth Centers Routine And Special Chemistry Test Volume Forecast
U.S.A., Birth Centers Profiles, Panels and Individual Tests
U.S.A., Birth Centers Routine And Special Chemistry Reagent Market Forecast by Test
U.S.A., Major Suppliers of Clinical Chemistry Diagnostic Products Estimated Market Shares
U.S.A., Major Suppliers of Clinical Chemistry Reagents, Estimated Market Shares
U.S.A., Major Suppliers of Clinical Chemistry Analyzers, Estimated Market Shares
U.S.A., Major Suppliers of Immunodiagnostic Products, Estimated Market Shares
U.S.A., Major Suppliers of Immunoassay Reagents, Estimated Market Shares
U.S.A., Major Suppliers of Immunoassay Analyzers, Estimated Market Shares
